Literature DB >> 21625148

Controversies in the adoption of new healthcare technologies.

Paul E Wallner, Michael L Steinberg, Andre A Konski.   

Abstract

Healthcare economists generally agree that the development and rapid introduction of new technologies and the expanding utilization of existing ones in national healthcare systems have been significant factors in the dramatic and potentially unsustainable growth in healthcare spending. Creating a rational system for evaluation of emerging technologies in this country has been complicated by 3 broad issues: the often conflicting needs and expectations of the variety of stakeholders; an arcane and often illogical system of service valuation and payment; and the lack of a standardized, transparent and validated approach to the measurement of 'value.' Recent discussions on reforming the elements of healthcare delivery have increased focus on these systemic shortcomings and conflicts. As a specialty that is clinically wedded to modern and increasingly expensive technology, radiation oncology has often been singled out for scrutiny. A thorough examination and understanding of the various factors and controversies involved in technology development, implementation and valuation analysis is essential to rational growth and development of the specialty.
Copyright © 2011 S. Karger AG, Basel.

Mesh:

Year:  2011        PMID: 21625148     DOI: 10.1159/000322401

Source DB:  PubMed          Journal:  Front Radiat Ther Oncol        ISSN: 0071-9676


  3 in total

Review 1.  Value: a framework for radiation oncology.

Authors:  Sewit Teckie; Susan A McCloskey; Michael L Steinberg
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

Review 2.  Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.

Authors:  Sophia C Kamran; Jay O Light; Jason A Efstathiou
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-04-09       Impact factor: 5.554

3.  Incremental cost-effectiveness of dobutamine stress cardiac magnetic resonance imaging in patients at intermediate risk for coronary artery disease.

Authors:  George Petrov; Sebastian Kelle; Eckart Fleck; Ernst Wellnhofer
Journal:  Clin Res Cardiol       Date:  2014-11-14       Impact factor: 5.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.